# Boots-Celltech Diagnostics, Inc.

- Location (FDA's records): Berkshire, England, GB
- FDA decisions: 20 (1984–1989): 20 510(k) clearances
- Product codes: LJC (3), CEP (2), CFT (1), LIO (1), LGC (1), GQG (1), JLM (1), JSM (1), GNX (1), GQN (1), LJP (1), CFL (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K871877: Ideia Herpes Simplex Virus Test (Nov 17, 1989)
- K880799: Modified Ideia Chlamydia Test (Dec 8, 1988)
- K880758: Sucrosep Specific Immunoradiometric Assay (Apr 18, 1988)
- K874875: Chemelia Free Thyroxine (FT4)/Enzyme Immuno. (Eia) (Mar 24, 1988)
- K872958: Imagen Influenza Virus a and B Testmi (Feb 24, 1988)
- K872843: Oveia (TM) Dual Analyte (Feb 2, 1988)
- K873625: Chemelia Enzyme Immunoassay for (TSH) (Oct 20, 1987)
- K872056: Modified (Directions for Use) for Ideia (TM) Test (Jun 15, 1987)

Source page: https://510kreport.com/company/boots-celltech-diagnostics